CYP1B1 and neoplasm: Consistent with our previous findings, we observed that CYP1B1 protein levels were significantly elevated in tissues exhibiting acquired resistance to sunitinib compared to primary tumour tissues without acquired resistance (Fig. 1F, S1H).